149 related articles for article (PubMed ID: 17543427)
1. A fusogenic peptide expressed on the surface of Salmonella enterica elicits CTL responses to a dengue virus epitope.
Luria-Perez R; Cedillo-Barron L; Santos-Argumedo L; Ortiz-Navarrete VF; Ocaña-Mondragon A; Gonzalez-Bonilla CR
Vaccine; 2007 Jun; 25(27):5071-85. PubMed ID: 17543427
[TBL] [Abstract][Full Text] [Related]
2. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
[TBL] [Abstract][Full Text] [Related]
3. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
Partidos CD; Vohra P; Steward MW
Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
[TBL] [Abstract][Full Text] [Related]
4. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
5. Induction of specific and flavivirus--Cross-reactive CTLs by immunization with a single dengue virus-derived CTL epitope peptide.
Masaki H; Fujii Y; Wakasa-Morimoto C; Toyosaki-Maeda T; Irimajiri K; Tomura TT; Kurane I
Virus Res; 2009 Sep; 144(1-2):188-94. PubMed ID: 19427342
[TBL] [Abstract][Full Text] [Related]
6. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.
Liu WT; Lin WT; Tsai CC; Chuang CC; Liao CL; Lin HC; Hung YW; Huang SS; Liang CC; Hsu HL; Wang HJ; Liu YT
Vaccine; 2006 Jul; 24(31-32):5852-61. PubMed ID: 16759760
[TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
[TBL] [Abstract][Full Text] [Related]
8. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
9. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
[TBL] [Abstract][Full Text] [Related]
10. Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus.
Izquierdo A; Bernardo L; Martin J; Santana E; Hermida L; Guillén G; Guzmán MG
Virus Res; 2008 Dec; 138(1-2):135-8. PubMed ID: 18796319
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
[TBL] [Abstract][Full Text] [Related]
12. Display and release of the Plasmodium falciparum circumsporozoite protein using the autotransporter MisL of Salmonella enterica.
Ruiz-Olvera P; Ruiz-Pérez F; Sepulveda NV; Santiago-Machuca A; Maldonado-Rodríguez R; Garcia-Elorriaga G; González-Bonilla C
Plasmid; 2003 Jul; 50(1):12-27. PubMed ID: 12826054
[TBL] [Abstract][Full Text] [Related]
13. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.
Valdés I; Bernardo L; Gil L; Pavón A; Lazo L; López C; Romero Y; Menendez I; Falcón V; Betancourt L; Martín J; Chinea G; Silva R; Guzmán MG; Guillén G; Hermida L
Virology; 2009 Nov; 394(2):249-58. PubMed ID: 19783271
[TBL] [Abstract][Full Text] [Related]
14. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
[TBL] [Abstract][Full Text] [Related]
15. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
[TBL] [Abstract][Full Text] [Related]
16. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
17. [Inoculation of plasmid expressing the dengue 2 NS1 gene elicits immunity in mice].
Yang CY; Chen Y; Yan HJ; Fang DY; Xue YH; Jiang LF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):71-3. PubMed ID: 16201480
[TBL] [Abstract][Full Text] [Related]
18. Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice.
Zulueta A; Martín J; Hermida L; Alvarez M; Valdés I; Prado I; Chinea G; Rosario D; Guillén G; Guzmán MG
Virus Res; 2006 Oct; 121(1):65-73. PubMed ID: 16781791
[TBL] [Abstract][Full Text] [Related]
19. Melanoma vaccine based on the vector of membrane fusogenic liposomes.
Qiang L; Yi J; Fu-De C
Pharmazie; 2004 Apr; 59(4):263-7. PubMed ID: 15125569
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
